Threat of dengue fever escalates globally
- July 30, 2023
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Threat of dengue fever escalates globally
Subject: Science and Technology
Section: Health
Context:
- The recent surge in dengue cases globally, including in new regions has been alarming and poses significant global health challenges. The World Health Organisation (WHO) forecasts the possibility of record-level cases this year due to global warming favouring disease-transmitting mosquitoes.
Dengue fever:
- Dengue fever, caused by the dengue virus (DENV), is a highly prevalent infectious disease estimated to be infecting over 400 million people each year as per the WHO.
- DENV is an RNA virus of the Flaviviridae family with four serotypes (DENV-1 to 4).
- Infection with one serotype provides lifelong immunity to that type, but subsequent infections with different serotypes can lead to severe, life-threatening forms of the disease.
- There is no specific antiviral treatment for dengue, so prevention relies on controlling mosquito populations and raising public awareness.
Outbreaks in 2023:
- Several regions in America, Brazil, Peru, Argentina, Chile, Uruguay, Paraguay, Bolivia and Egypt’s Qena province have reported cases of Dengue fever.
- Sudan in Africa, Middle-east countries and some countries in Asia including Bangladesh, Thailand, Malaysia, Cambodia, and India have also reported the increased number of dengue cases.
- In India, states like Kerala, Odisha, Assam, Tamil Nadu, Maharashtra, West Bengal, and Karnataka are reporting large numbers of dengue cases.
- Changing climatic conditions in Europe, such as increased heat waves, floods, and prolonged hot summers, have created favourable environments for dengue-causing mosquito species.
- The European Centre for Disease Prevention and Control (ECDC) has warned of an increase in DENV infections across the region.
Vaccine for Dengue fever:
- Recently, Takeda released the first vaccine for the disease, which has been approved in a few countries.
- The vaccine has modest efficacy in preventing severe disease but still has much ground to cover in terms of preventing infection, providing uniform protection against all serotypes, and ensuring long-term immunity.
For further details on Dengue virus: https://optimizeias.com/dengue/